This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
J. Kim, J. M. Basak, and D. M. Holtzman, “The Role of Apolipoprotein E in Alzheimer’s Disease,” Neuron. 2009; 63(3): 287–303,KimJ.BasakJ. M.andHoltzmanD. M.“The Role of Apolipoprotein E in Alzheimer’s Disease,”Neuron200963328730310.1016/j.neuron.2009.06.026304444619679070Search in Google Scholar
O. MC, M. SE, Z. G, N. AC, and M. CE, “APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review,” Cortex. 2018; 104: 103–123.MCO.SEM.GZ.ACN.andCEM.“APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review,”Cortex201810410312310.1016/j.cortex.2018.03.02529800787Search in Google Scholar
G. Jun et al., “Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region,” Arch Neurol. 2012; 69(10): 1270–1279.JunG.et al“Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region,”Arch Neurol201269101270127910.1001/archneurol.2012.2052357965922869155Search in Google Scholar
L. A. Farrer et al., “Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis,” JAMA. 1997; 278(16): 1349–1356.FarrerL. A.et al“Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis,”JAMA1997278161349135610.1001/jama.1997.03550160069041Search in Google Scholar
S. M. Laws, E. Hone, S. Gandy, and R. N. Martins, “Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription,” J. Neurochem. 2003; 84(6): 1215–1236.LawsS. M.HoneE.GandyS.andMartinsR. N.“Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription,”J. Neurochem20038461215123610.1046/j.1471-4159.2003.01615.x12614323Search in Google Scholar
S. Emrani, H. A. Arain, C. DeMarshall, and T. Nuriel, “APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review,” Alzheimers. Res. Ther. 2020; 12(1): 141.EmraniS.ArainH. A.DeMarshallC.andNurielT.“APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review,”Alzheimers. Res. Ther202012114110.1186/s13195-020-00712-4764347933148345Search in Google Scholar
R. Cacciaglia et al., “Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease,” Alzheimer’s Dement. 2018; 14(7): 902–912.CacciagliaR.et al“Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease,”Alzheimer’s Dement201814790291210.1016/j.jalz.2018.01.01629605385Search in Google Scholar
K. Chen et al., “Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares,” Neuroimage. 2012; 60(4): 2316.ChenK.et al“Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares,”Neuroimage2012604231610.1016/j.neuroimage.2012.02.005332564222348880Search in Google Scholar
A. Montagne et al., “APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline,” Nature. 2020; 581(7806): 71–76.MontagneA.et al“APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline,”Nature20205817806717610.1038/s41586-020-2247-3725000032376954Search in Google Scholar
S. Moreno-Grau et al., “Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results,” 2017.Moreno-GrauS.et al“Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results,”201710.1016/j.jalz.2017.06.208Search in Google Scholar
World Medical Association, “Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols,” World Med. Assoc. 2013; 1964: 29–32.World Medical Association“Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols,”World Med. Assoc201319642932Search in Google Scholar
M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” J. Psychiatr. Res. 1975; 12(3): 189–198.FolsteinM. F.FolsteinS. E.andMcHughP. R.“‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,”J. Psychiatr. Res197512318919810.1016/0022-3956(75)90026-61202204Search in Google Scholar
E. Strauss, E. M. S. Sherman, and O. Spreen, A compendium of neuropsychological tests: Administration, norms, and commentary, 3rd ed. New York, NY, US: Oxford University Press, 2006.StraussE.ShermanE. M. S.andSpreenO.A compendium of neuropsychological tests: Administration, norms, and commentary, 3rd edNew York, NY, USOxford University Press2006Search in Google Scholar
A. Rey, “L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.],” Arch. Psychol. (Geneve). 1941; 28: 215–285.ReyA.“L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.],”Arch. Psychol. (Geneve)194128215285Search in Google Scholar
Z. Shao, E. Janse, K. Visser, and A. S. Meyer, “What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults,” Front. Psychol. 2014; 5: 1–10.ShaoZ.JanseE.VisserK.andMeyerA. S.“What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults,”Front. Psychol2014511010.3389/fpsyg.2014.00772410645325101034Search in Google Scholar
M. D. Lezak, D. B. Howieson, D. W. Loring, and J. S. Fischer, Neuropsychological assessment. Oxford University Press, USA, 2004.LezakM. D.HowiesonD. B.LoringD. W.andFischerJ. S.Neuropsychological assessmentOxford University PressUSA2004Search in Google Scholar
L. M. Nichols et al., “Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults,” Arch. Gen. Psychiatry. 2012; 69(8): 804–813.NicholsL. M.et al“Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults,”Arch. Gen. Psychiatry201269880481310.1001/archgenpsychiatry.2011.189322868934Search in Google Scholar
G. A. Rodriguez, M. P. Burns, E. J. Weeber, and G. W. Rebeck, “Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex,” Learn. Mem. 2013; 20(5): 256–266.RodriguezG. A.BurnsM. P.WeeberE. J.andRebeckG. W.“Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex,”Learn. Mem201320525626610.1101/lm.030031.112363048923592036Search in Google Scholar
T. Iachini, A. Iavarone, V. P. Senese, F. Ruotolo, and G. Ruggiero, “Visuospatial Memory in Healthy Elderly, AD and MCI: A Review,” Curr. Aging Sci. 2009; 2: 43–59.IachiniT.IavaroneA.SeneseV. P.RuotoloF.andRuggieroG.“Visuospatial Memory in Healthy Elderly, AD and MCI: A Review,”Curr. Aging Sci20092435910.2174/187460981090201004320021398Search in Google Scholar
R. J. Piers, Y. Liu, T. F. A. Ang, Q. Tao, R. Au, and W. Q. Qiu, “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study,” J. Alzheimer’s Dis. 2021; 80(3): 1269–1279.PiersR. J.LiuY.AngT. F. A.TaoQ.AuR.andQiuW. Q.“Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study,”J. Alzheimer’s Dis20218031269127910.3233/JAD-200998817207833646152Search in Google Scholar
F. Mashayekhi, S. Sadigh-Eteghad, A. Naseri, M. Asadi, N. A. Garravnd, and M. Talebi, “ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study,” Neurol. Sci. 2021. 2021; 1–8.MashayekhiF.Sadigh-EteghadS.NaseriA.AsadiM.GarravndN. A.andTalebiM.“ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study,”Neurol. Sci. 202120211–810.1007/s10072-021-05383-z34120271Search in Google Scholar
I. Reinvang, T. Espeseth, and L. T. Westlye, “APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease,” Neurosci. Biobehav. Rev. 2013; 37: 1322–1335.ReinvangI.EspesethT.andWestlyeL. T.“APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease,”Neurosci. Biobehav. Rev2013371322133510.1016/j.neubiorev.2013.05.00623701948Search in Google Scholar